decisionhealth Newsletters, Part B News - 2023 Issue 3 (March)
CMS publishes FAQ on modifiers JW and JZ
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a CMS FAQ on Medicare’s discarded drug policy and the use of drug waste modifiers. It is relevant to providers, billing staff, and coding professionals who work with separately payable Part B drugs and need to understand the general policy context, timing, and claim-reporting guidance discussed by CMS.
Why This Topic Matters
The FAQ clarifies CMS policy changes tied to drug waste reporting and explains when the agency expects these modifiers to appear on claims. This matters for teams that bill Medicare Part B drug services and want to stay aligned with current CMS guidance and implementation timing.
What You Will Learn
- What CMS’s FAQ says about Medicare’s discarded drug policy
- Which broad types of drugs are affected by the policy
- How CMS frames the timing of the modifier update
- What general billing and compliance issues the FAQ addresses
- Why CMS says the policy was created
Who Should Read This
- Medical coders
- Billing staff
- Revenue cycle teams
- Compliance professionals
- Physician practice administrators
- Hospital outpatient billing teams
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com